Not Yet Recruiting PHASE2/PHASE3 INTERVENTIONAL 2-arm
NCT07166393
Valproic AcId for Traumatic BRAin INjury Trial (VIBRANT)
Multi-institutional Phase 2/3 Trial of Valproic Acid in Patients With Moderate to Severe Traumatic Brain Injury
Sponsor: Northwestern University
Updated 1 time since 2025 Last updated: Sep 16, 2025 Started: May 31, 2026 Primary completion: Feb 28, 2030 Completion: Dec 31, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07166393, this PHASE2/PHASE3 trial focuses on Moderate Traumatic Brain Injury (TBI) and Severe Traumatic Brain Injury and remains actively recruiting participants. Sponsored by Northwestern University, it has been updated 1 time since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2/PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Northwestern University
- United States Department of Defense
Data source: Northwestern University
For direct contact, visit the study record on ClinicalTrials.gov .